loftying

               The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.a  a

           The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.a

        The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.  

        The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.

       The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.

      The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.

    The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.

   The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.

   The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.

   The Valens Company has  strengthened  its capacity to  provide  an extended product offering to domestic and international markets with the  acquisition  of Green Roads.  Additionally , the acquisition gives a trusted and top-tier CBD  health  and wellness brand with a well-established  manufacturing  and distribution platform an immediate entry  point  into the US  market . In 2021, the Green Roads Acquisition is anticipated to increase the  company’s  value. The transaction represents roughly 4.5x  fiscal  2022 EBITDA if all Milestones are reached in 2022. Pro forma results in a  company  with total  revenue  of C$111.6M in 20204 from the union of Valens and  Green  Roads.